Daily Stocks Digest From May 30, 2026

Inflection Point01STOCKS

Replimune shares surged 85.7% to close at $8.69 on Friday following an announcement that the company and FDA have aligned on a path forward for resubmission of its Biologics License Application.
The agreement allows the company to resubmit its application for RP1 in combination with Nivolumab to treat advanced melanoma in the coming days.
This follows two prior FDA rejections over study design concerns, with the company now positioned to resubmit after regulatory discussions.

Trend Shift02STOCKS

Dell Technologies shares jumped 32.8% to close at $420.91 on Friday following a blowout first-quarter earnings report.
The computing giant raised its full-year outlook as first-quarter AI-optimized server revenue surged 757%, driven by booming demand for artificial intelligence infrastructure.
Trading volume reached 38.18 million shares, representing more than five times its recent daily average.

Outlier03STOCKS

NetApp shares surged 22.4% to close at $174.29 on Friday after reporting first-quarter financial results that beat Wall Street estimates.
The data storage company issued strong forward guidance on an AI spending boom, breaking a 26-year-old record for the stock.
Trading volume reached 15.90 million shares, representing 5.5 times its 20-day average of 2.90 million shares.

Trend Shift04STOCKS

Okta shares jumped 30.1% to close at $123.27 on Friday after reporting first-quarter results that beat Wall Street's sales and earnings estimates.
The identity management company raised its full-year guidance, driven by accelerating subscription growth and emerging AI-driven identity product demand.
Trading volume reached 17.18 million shares, which is 5.5 times its 20-day average of 3.13 million shares.